RGC | Regencell Bioscience Holdings Limited Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2024-06-30	2023-06-30	2022-06-30	2021-06-30	2020-06-30	2019-06-30	2017-12-31	2016-12-31	2015-12-31	2015-01-01	2013-12-26	2012-12-27	2010-12-30	2009-12-31	2009-01-01	2007-12-27	2006-12-28	2004-12-30	2004-01-01	2002-12-26
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	3.16B	3.20B	3.13B	2.99B	3.04B	2.82B	2.81B	2.89B	2.77B	2.66B	2.60B	2.47B	2.49B	2.14B
Cost of Revenue	745.59K	769.69K	604.40K	26.46K	9.52K	N/A	123.00M	1.23B	1.21B	111.00M	111.00M	101.00M	101.00M	1.16B	106.00M	103.00M	104.00M	94.00M	92.00M	84.00M
Gross Profit	-745.59K	-769.69K	-604.40K	-26.46K	-9.52K	N/A	3.04B	1.97B	1.92B	2.88B	2.93B	2.72B	2.71B	1.74B	2.67B	2.56B	2.49B	2.37B	2.40B	2.06B
Operating Expenses	3.99M	6.27M	7.62M	1.38M	812.37K	390.99K	1.31B	1.63B	1.58B	1.19B	1.16B	1.05B	1.23B	1.42B	2.49B	2.34B	2.29B	2.15B	2.11B	1.86B
Selling, General & Admin	2.92M	4.69M	5.11M	943.04K	426.14K	162.77K	86.60M	512.20M	500.30M	74.40M	73.70M	68.80M	66.70M	443.00M	62.00M	63.00M	65.00M	63.00M	62.00M	65.00M
Research & Development	1.07M	1.58M	2.51M	438.32K	386.23K	228.22K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Operating Expenses	N/A	211.34K	23.21K	34.62K	N/A	N/A	1.22B	1.11B	1.08B	1.12B	1.09B	985.30M	1.17B	980.40M	2.42B	2.28B	2.22B	2.08B	2.05B	1.79B
Operating Income	-4.74M	-6.27M	-7.62M	-1.38M	-812.37K	-390.99K	271.70M	344.20M	339.00M	306.40M	339.80M	334.20M	215.80M	313.40M	284.00M	322.00M	308.00M	321.00M	379.00M	283.00M
Other Expenses / Income	373.50K	211.34K	23.21K	34.62K	N/A	N/A	-57.80M	-62.50M	-85.70M	-127.80M	-75.20M	-98.30M	-140.10M	-156.20M	-161.00M	283.00M	-164.00M	-179.00M	-73.00M	-75.00M
Before Tax Income	-4.36M	-6.06M	-7.59M	-1.35M	-812.37K	-390.99K	213.90M	281.70M	253.30M	178.60M	264.60M	235.90M	75.70M	157.20M	123.00M	605.00M	144.00M	142.00M	306.00M	208.00M
Income Tax Expenses	312.13K	-191.20K	-171.83K	-210.10K	-1.00	-390.00	101.60M	111.20M	100.10M	73.40M	107.00M	91.20M	48.70M	61.90M	50.00M	242.00M	57.00M	59.00M	121.00M	89.00M
Net Income	-4.30M	-5.87M	-7.42M	-1.35M	-812.37K	-390.99K	112.30M	170.40M	153.40M	105.60M	157.70M	144.80M	77.60M	95.50M	72.00M	363.00M	86.00M	82.00M	185.00M	117.00M
Interest Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	152.80M	-124.00M	-112.00M	-125.00M	-95.00M	-72.00M	61.00M
Basic Shares Outstanding	13.01M	13.01M	13.01M	12.64M	12.64M	12.64M	156.34M	156.79M	156.45M	155.29M	154.83M	154.17M	153.40M	153.05M	1.16M	5.75M	1.31M	143.86M	138.06M	140.96M
Diluted Shares Outstanding	13.01M	13.01M	13.01M	12.64M	12.64M	12.64M	156.99M	156.80M	156.50M	156.31M	155.72M	154.99M	154.52M	154.10M	1.16M	5.75M	1.31M	149.09M	142.31M	148.10M
EBITDA	-3.62M	-5.29M	-6.99M	-1.35M	-802.86K	-390.99K	468.70M	512.30M	470.30M	391.00M	469.20M	422.20M	352.50M	512.10M	200.00M	676.00M	215.00M	220.00M	392.00M	401.00M
EBITDA Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	14.82%	16.02%	15.04%	13.08%	15.44%	14.95%	12.55%	17.70%	7.22%	25.40%	8.28%	8.91%	15.75%	18.74%
EBIT	-3.99M	-6.06M	-7.59M	-1.56M	-812.37K	-391.38K	213.90M	281.60M	253.50M	179.00M	264.70M	236.00M	126.30M	310.20M	-2.00M	493.00M	18.00M	46.00M	234.00M	267.00M
EBIT Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.76%	8.81%	8.11%	5.99%	8.71%	8.36%	4.50%	10.72%	-0.07%	18.53%	0.69%	1.86%	9.40%	12.48%
Financial Year End	2024-06-30	2023-06-30	2022-06-30	2021-06-30	2020-06-30	2019-06-30	2017-12-31	2016-12-31	2015-12-31	2015-01-01	2013-12-26	2012-12-27	2010-12-30	2009-12-31	2009-01-01	2007-12-27	2006-12-28	2004-12-30	2004-01-01	2002-12-26